Biolife Solutions (BLFS) Equity Income (2017 - 2019)

Biolife Solutions (BLFS) has reported Equity Income for 3 consecutive years, with -$291000.0 the latest figure, recorded in Q3 2019.

• On a quarterly basis, Equity Income fell 576.74% year-over-year to -$291000.0 in Q3 2019; TTM through Dec 2020 was -$291000.0, a 60.68% increase from a year earlier, with the FY2019 full-year figure at -$739000.0, down 9.97% from the prior year.
• Equity Income was -$291000.0 for Q3 2019 at Biolife Solutions, down from -$217000.0 in the prior quarter.
• Over five years, Equity Income peaked at -$43000.0 in Q3 2018 and troughed at -$309000.0 in Q4 2018.
• A 3-year average of -$219818.2 and a median of -$229368.0 in 2017 frame the typical range for Equity Income.
• Across the five-year window, Equity Income soared 80.25% in 2018 and slumped 576.74% in 2019, its largest moves.
• Over 3 years, Equity Income stood at -$297792.0 in 2017, then retreated by 3.76% to -$309000.0 in 2018, then increased by 5.83% to -$291000.0 in 2019.
• The last three Equity Income figures came in at -$291000.0 (Q3 2019), -$217000.0 (Q2 2019), and -$232000.0 (Q1 2019), per Business Quant data.